loading page

Laparoscopic liver resection versus open liver resection for recurrent liver cancer: A systematic review and meta-analysis of PSM studies
  • +2
  • Hui Zhang,
  • Wenkai Jiang,
  • Xinlong Chen,
  • Xin Li,
  • Yan Du
Hui Zhang
Lanzhou University Second Hospital
Author Profile
Wenkai Jiang
Lanzhou University
Author Profile
Xinlong Chen
The First Affiliated Hospital of Xi'an Jiaotong University
Author Profile
Xin Li
Lanzhou University Second Hospital
Author Profile
Yan Du
Lanzhou University

Corresponding Author:[email protected]

Author Profile

Abstract

Background: Laparoscopic liver resection (LLR) has not been widely accepted for recurrent liver cancer (RLC). This study aims to conduct a systematic review of the current literature for determining LLR effectiveness and safety for patients with RLC. Methods: Before April 2022, a comprehensive literature search was undertaken in Web of Science, PubMed, and Embase relied on a specified search strategy for eligible propensity score matching (PSM) studies comparing LLR or OLR. Meta-analysis of operative times, duration of stay, mortality, blood loss, overall survival rate, blood transfusion, recurrence-free survival rate, and overall complications was undertaken using a random/fixed-effects model. Results: Eight PSM studies of LLR versus OLR were incorporated, including 1128 patients. The current meta-analysis revealed nonsignificant variations between the two groups in overall survival rate, operation time, blood transfusion, mortality, overall complications, and long-term recurrence-free survival rate. Alternatively, when LLR is compared to OLR, LLR results in lower blood loss (p=0.002) and a shorter hospitalization (p=0.04). Conclusion: Although both techniques appear equal, LLR seems to have certain advantages over OLR. Notably, the evidence quality is generally confined to cohort studies, necessitating the performance of a high-quality randomized trial that compares both approaches. Keywords: Laparoscopic surgery, Liver resection, Recurrent liver cancer, Propensity score matching, Meta-analysis.
15 Aug 2023Submitted to Cancer Reports
17 Aug 2023Submission Checks Completed
17 Aug 2023Assigned to Editor
17 Aug 2023Review(s) Completed, Editorial Evaluation Pending
22 Aug 2023Reviewer(s) Assigned
01 Nov 2023Editorial Decision: Revise Major